Cargando…
TREC mediated oncogenesis in human immature T lymphoid malignancies preferentially involves ZFP36L2
The reintegration of excised signal joints resulting from human V(D)J recombination was described as a potent source of genomic instability in human lymphoid cancers. However, such molecular events have not been recurrently reported in clinical patient lymphoma/leukemia samples. Using a specifically...
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10332067/ https://www.ncbi.nlm.nih.gov/pubmed/37430263 http://dx.doi.org/10.1186/s12943-023-01794-y |
_version_ | 1785070368439926784 |
---|---|
author | Balducci, Estelle Steimlé, Thomas Smith, Charlotte Villarese, Patrick Feroul, Mélanie Payet-Bornet, Dominique Kaltenbach, Sophie Couronné, Lucile Lhermitte, Ludovic Touzart, Aurore Dourthe, Marie-Emilie Simonin, Mathieu Baruchel, André Dombret, Hervé Ifrah, Norbert Boissel, Nicolas Nadel, Bertrand Macintyre, Elizabeth Cieslak, Agata Asnafi, Vahid |
author_facet | Balducci, Estelle Steimlé, Thomas Smith, Charlotte Villarese, Patrick Feroul, Mélanie Payet-Bornet, Dominique Kaltenbach, Sophie Couronné, Lucile Lhermitte, Ludovic Touzart, Aurore Dourthe, Marie-Emilie Simonin, Mathieu Baruchel, André Dombret, Hervé Ifrah, Norbert Boissel, Nicolas Nadel, Bertrand Macintyre, Elizabeth Cieslak, Agata Asnafi, Vahid |
author_sort | Balducci, Estelle |
collection | PubMed |
description | The reintegration of excised signal joints resulting from human V(D)J recombination was described as a potent source of genomic instability in human lymphoid cancers. However, such molecular events have not been recurrently reported in clinical patient lymphoma/leukemia samples. Using a specifically designed NGS-capture pipeline, we here demonstrated the reintegration of T-cell receptor excision circles (TRECs) in 20/1533 (1.3%) patients with T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL). Remarkably, the reintegration of TREC recurrently targeted the tumor suppressor gene, ZFP36L2, in 17/20 samples. Thus, our data identified a new and hardly detectable mechanism of gene deregulation in lymphoid cancers providing new insights in human oncogenesis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12943-023-01794-y. |
format | Online Article Text |
id | pubmed-10332067 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-103320672023-07-11 TREC mediated oncogenesis in human immature T lymphoid malignancies preferentially involves ZFP36L2 Balducci, Estelle Steimlé, Thomas Smith, Charlotte Villarese, Patrick Feroul, Mélanie Payet-Bornet, Dominique Kaltenbach, Sophie Couronné, Lucile Lhermitte, Ludovic Touzart, Aurore Dourthe, Marie-Emilie Simonin, Mathieu Baruchel, André Dombret, Hervé Ifrah, Norbert Boissel, Nicolas Nadel, Bertrand Macintyre, Elizabeth Cieslak, Agata Asnafi, Vahid Mol Cancer Correspondence The reintegration of excised signal joints resulting from human V(D)J recombination was described as a potent source of genomic instability in human lymphoid cancers. However, such molecular events have not been recurrently reported in clinical patient lymphoma/leukemia samples. Using a specifically designed NGS-capture pipeline, we here demonstrated the reintegration of T-cell receptor excision circles (TRECs) in 20/1533 (1.3%) patients with T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL). Remarkably, the reintegration of TREC recurrently targeted the tumor suppressor gene, ZFP36L2, in 17/20 samples. Thus, our data identified a new and hardly detectable mechanism of gene deregulation in lymphoid cancers providing new insights in human oncogenesis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12943-023-01794-y. BioMed Central 2023-07-10 /pmc/articles/PMC10332067/ /pubmed/37430263 http://dx.doi.org/10.1186/s12943-023-01794-y Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Correspondence Balducci, Estelle Steimlé, Thomas Smith, Charlotte Villarese, Patrick Feroul, Mélanie Payet-Bornet, Dominique Kaltenbach, Sophie Couronné, Lucile Lhermitte, Ludovic Touzart, Aurore Dourthe, Marie-Emilie Simonin, Mathieu Baruchel, André Dombret, Hervé Ifrah, Norbert Boissel, Nicolas Nadel, Bertrand Macintyre, Elizabeth Cieslak, Agata Asnafi, Vahid TREC mediated oncogenesis in human immature T lymphoid malignancies preferentially involves ZFP36L2 |
title | TREC mediated oncogenesis in human immature T lymphoid malignancies preferentially involves ZFP36L2 |
title_full | TREC mediated oncogenesis in human immature T lymphoid malignancies preferentially involves ZFP36L2 |
title_fullStr | TREC mediated oncogenesis in human immature T lymphoid malignancies preferentially involves ZFP36L2 |
title_full_unstemmed | TREC mediated oncogenesis in human immature T lymphoid malignancies preferentially involves ZFP36L2 |
title_short | TREC mediated oncogenesis in human immature T lymphoid malignancies preferentially involves ZFP36L2 |
title_sort | trec mediated oncogenesis in human immature t lymphoid malignancies preferentially involves zfp36l2 |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10332067/ https://www.ncbi.nlm.nih.gov/pubmed/37430263 http://dx.doi.org/10.1186/s12943-023-01794-y |
work_keys_str_mv | AT balducciestelle trecmediatedoncogenesisinhumanimmaturetlymphoidmalignanciespreferentiallyinvolveszfp36l2 AT steimlethomas trecmediatedoncogenesisinhumanimmaturetlymphoidmalignanciespreferentiallyinvolveszfp36l2 AT smithcharlotte trecmediatedoncogenesisinhumanimmaturetlymphoidmalignanciespreferentiallyinvolveszfp36l2 AT villaresepatrick trecmediatedoncogenesisinhumanimmaturetlymphoidmalignanciespreferentiallyinvolveszfp36l2 AT feroulmelanie trecmediatedoncogenesisinhumanimmaturetlymphoidmalignanciespreferentiallyinvolveszfp36l2 AT payetbornetdominique trecmediatedoncogenesisinhumanimmaturetlymphoidmalignanciespreferentiallyinvolveszfp36l2 AT kaltenbachsophie trecmediatedoncogenesisinhumanimmaturetlymphoidmalignanciespreferentiallyinvolveszfp36l2 AT couronnelucile trecmediatedoncogenesisinhumanimmaturetlymphoidmalignanciespreferentiallyinvolveszfp36l2 AT lhermitteludovic trecmediatedoncogenesisinhumanimmaturetlymphoidmalignanciespreferentiallyinvolveszfp36l2 AT touzartaurore trecmediatedoncogenesisinhumanimmaturetlymphoidmalignanciespreferentiallyinvolveszfp36l2 AT dourthemarieemilie trecmediatedoncogenesisinhumanimmaturetlymphoidmalignanciespreferentiallyinvolveszfp36l2 AT simoninmathieu trecmediatedoncogenesisinhumanimmaturetlymphoidmalignanciespreferentiallyinvolveszfp36l2 AT baruchelandre trecmediatedoncogenesisinhumanimmaturetlymphoidmalignanciespreferentiallyinvolveszfp36l2 AT dombretherve trecmediatedoncogenesisinhumanimmaturetlymphoidmalignanciespreferentiallyinvolveszfp36l2 AT ifrahnorbert trecmediatedoncogenesisinhumanimmaturetlymphoidmalignanciespreferentiallyinvolveszfp36l2 AT boisselnicolas trecmediatedoncogenesisinhumanimmaturetlymphoidmalignanciespreferentiallyinvolveszfp36l2 AT nadelbertrand trecmediatedoncogenesisinhumanimmaturetlymphoidmalignanciespreferentiallyinvolveszfp36l2 AT macintyreelizabeth trecmediatedoncogenesisinhumanimmaturetlymphoidmalignanciespreferentiallyinvolveszfp36l2 AT cieslakagata trecmediatedoncogenesisinhumanimmaturetlymphoidmalignanciespreferentiallyinvolveszfp36l2 AT asnafivahid trecmediatedoncogenesisinhumanimmaturetlymphoidmalignanciespreferentiallyinvolveszfp36l2 |